Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature

Rheumatology Oxford Journal

Fecha de publicación: 1 July 2018

DOI: https://doi.org/10.1093/rheumatology/kex249

Autores: Giulia Pazzola, Francesco Muratore, Nicolò Pipitone, Filippo Crescentini, Patrice Cacoub, Luigi Boiardi, Lucía Spaggiari, Cloe Comarmond, Stefania Croci, David Saadoun …

Background: We conducted a retrospective study on seven TAK patients treated with RTX. Six of the seven patients had a disease refractory to high dose glucocorticoids and conventional immunosuppressive and/or biologic agents.